Search alternatives:
de decrease » we decrease (Expand Search), _ decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a de » _ de (Expand Search), a d (Expand Search), i de (Expand Search)
de decrease » we decrease (Expand Search), _ decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a de » _ de (Expand Search), a d (Expand Search), i de (Expand Search)
-
19681
Overview of the regulation of the purine metabolic pathway by gliotoxin and H<sub>2</sub>O<sub>2</sub>, either alone or in combination.
Published 2014“…<p>(a) Purine-related enzymes and pathways undergoing an increase in expression, relative to the solvent control, are indicated in red and decreased expression is indicated in green. …”
-
19682
-
19683
Endocytosis efficiency of VAMPs 2, 3, and 8.
Published 2013“…Although there is some variability from one line to another, the two non-CALM-binding mutants are always expressed at much higher levels than wild-type VAMP8 or the P3P4 mutant. d, The differences in expression are due to differences in degradation, not in synthesis. When de novo protein synthesis was blocked with cycloheximide, the levels of the two CALM-binding constructs decreased rapidly over four hours, while the levels of the two non-CALM-binding mutants were not appreciably affected.…”
-
19684
-
19685
-
19686
Table_3_Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial.PDF
Published 2022“…</p>Methods<p>In order to determine the additional effect of carbohydrate restriction in addition to a fixed body weight loss, we randomly assigned 72 adults with T2D and obesity (mean ± SD HbA<sub>1c</sub> 7.4 ± 0.7%, BMI 33 ± 5 kg/m<sup>2</sup>) to a carbohydrate-reduced high-protein diet (CRHP; energy percent from carbohydrate/protein/fat: 30/30/40) or an isocaloric conventional diabetes diet (CD; 50/17/33) for 6 weeks. …”
-
19687
Image_1_Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial.PDF
Published 2022“…</p>Methods<p>In order to determine the additional effect of carbohydrate restriction in addition to a fixed body weight loss, we randomly assigned 72 adults with T2D and obesity (mean ± SD HbA<sub>1c</sub> 7.4 ± 0.7%, BMI 33 ± 5 kg/m<sup>2</sup>) to a carbohydrate-reduced high-protein diet (CRHP; energy percent from carbohydrate/protein/fat: 30/30/40) or an isocaloric conventional diabetes diet (CD; 50/17/33) for 6 weeks. …”
-
19688
Table_1_Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial.PDF
Published 2022“…</p>Methods<p>In order to determine the additional effect of carbohydrate restriction in addition to a fixed body weight loss, we randomly assigned 72 adults with T2D and obesity (mean ± SD HbA<sub>1c</sub> 7.4 ± 0.7%, BMI 33 ± 5 kg/m<sup>2</sup>) to a carbohydrate-reduced high-protein diet (CRHP; energy percent from carbohydrate/protein/fat: 30/30/40) or an isocaloric conventional diabetes diet (CD; 50/17/33) for 6 weeks. …”
-
19689
Table_2_Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial.PDF
Published 2022“…</p>Methods<p>In order to determine the additional effect of carbohydrate restriction in addition to a fixed body weight loss, we randomly assigned 72 adults with T2D and obesity (mean ± SD HbA<sub>1c</sub> 7.4 ± 0.7%, BMI 33 ± 5 kg/m<sup>2</sup>) to a carbohydrate-reduced high-protein diet (CRHP; energy percent from carbohydrate/protein/fat: 30/30/40) or an isocaloric conventional diabetes diet (CD; 50/17/33) for 6 weeks. …”
-
19690
Beta-catenin signaling in the E14.5 cortex.
Published 2010“…Tbr2 staining suggests a rostral low to caudal gradient. Scale bars are 200 µm (<b>A</b>) 50 µm (<b>B</b>) and 500 µm (<b>C</b>).…”
-
19691
Myocyte death not vessel density is affected by age.
Published 2010“…<p>(A) Representative pictomicrographs of vascular density from BMTx mice. …”
-
19692
-
19693
Table1_Case Report: The novel hemizygous mutation in the SSR4 gene caused congenital disorder of glycosylation type iy: A case study and literature review.xls
Published 2022“…</p><p>Results: WES analysis identified a de novo hemizygous variant c.269G>A (p.Trp90*) of SSR4 gene in the proband with psychomotor retardation, microcephaly, abnormal facial features, and nystagmus. …”
-
19694
A Novel sLRP6E1E2 Inhibits Canonical Wnt Signaling, Epithelial-to-Mesenchymal Transition, and Induces Mitochondria-Dependent Apoptosis in Lung Cancer
Published 2012“…We designed a Wnt antagonist sLRP6E1E2, and generated a replication-incompetent adenovirus (Ad), dE1-k35/sLRP6E1E2, and a replication-competent oncolytic Ad, RdB-k35/sLRP6E1E2, both expressing sLRP6E1E2. sLRP6E1E2 prevented Wnt-mediated stabilization of cytoplasmic β-catenin, decreased Wnt/β-catenin signaling and cell proliferation via the mitogen-activated protein kinase, and phosphatidylinositol 3-kinase pathways. sLRP6E1E2 induced apoptosis, cytochrome <em>c</em> release, and increased cleavage of PARP and caspase-3. sLRP6E1E2 suppressed growth of the human lung tumor xenograft, and reduced motility and invasion of cancer cells. …”
-
19695
-
19696
-
19697
Data_Sheet_1_Lung function benefits of traditional Chinese medicine Qiju granules against fine particulate air pollution exposure: a randomized controlled trial.ZIP
Published 2024“…Forced expiratory volume in one second (FEV<sub>1</sub>), peak expiratory flow (PEF), maximal mid-expiratory flow (MMEF), forced expiratory flow at 75% of forced vital capacity (FVC) (FEF<sub>75</sub>), forced expiratory flow at 50% of FVC (FEF<sub>50</sub>), and forced expiratory flow at 25% of FVC (FEF<sub>25</sub>) were significantly decreased due to PM<sub>2.5</sub> exposure in the control group. …”
-
19698
-
19699
-
19700